Researchers at National Jewish Health are conducting a clinical research study of RPT904, an investigational treatment, to evaluate whether RPT904 may increase the amount of food allergen participants can safely tolerate with fewer doses than available treatments.
.jpg?lang=en-US&ext=.jpg)